Topic · page 12 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 441–480 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

Diabetes Obes Metab1 Jun 2026
Identification of Frailty Subtypes in A frican A merican Adults With and Without Type 2 Diabetes: A Latent Class Analysis From the J ackson H eart S tudy
Cross-sectional study
JAMA Netw Open1 Jun 2026
Long-Term Resistance Training and Risk of Type 2 Diabetes
Cohort study
JAMA Netw Open1 Jun 2026
Timing of Antidiabetic Medication Initiation and Risk of Cardiovascular Events and Mortality
Cohort study
Diabetes Obes Metab31 May 2026
Evaluation of the Safety, Efficacy and Pharmacokinetics of BGM0504 in Chinese Adults With Type 2 Diabetes: A Multicentre, Randomised, Controlled and Double‐Blind Phase II Trial
Randomized controlled trial
Diabetes Obes Metab31 May 2026
Semaglutide Injection in Indian Patients With Type 2 Diabetes Mellitus: A Randomised, Phase III , Active‐Controlled Study
Randomized controlled trial
Diabetes Obes Metab31 May 2026
The Effect of Canagliflozin Dose on Renal and Cardiovascular Outcomes in Type 2 Diabetes and High Cardiovascular Risk
Secondary analysis
Diabetes Obes Metab31 May 2026
The Impact of GLP ‐1‐Based Therapies on Cardiovascular Outcomes in Type 2 Diabetes: A Comprehensive Systematic Review and Network Meta‐Analysis
Meta-analysis
Diabetes Obes Metab31 May 2026
Trends in Potentially Avoidable Hospitalisations Among People With Diabetes in Ireland; 2015–2024
Cohort study
Diabetes Res Clin Pract28 May 2026
Glucagon-like peptide-1 receptor agonists versus sodium-glucose cotransporter-2 inhibitors in adults with type 2 diabetes and atrial fibrillation: a multicenter comparative effectiveness cohort study of cardiovascular and arrhythmic outcomes
Cohort study
Cardiovasc Diabetol28 May 2026
Large-scale multi-omics enhance risk prediction for type 2 diabetes
Diagnostic or prognostic study
Cardiovasc Diabetol28 May 2026
Incidence, risk factors and sequelae of long/post-COVID in people with diabetes compared to people without diabetes in Germany (longcovid-diab): a study protocol
Trial design
Diabetes Obes Metab28 May 2026
Risk of Psychiatric Worsening With GLP ‐1 Receptor Agonist Use in Patients With Type 2 Diabetes and Treated Depression
Cohort study
Int J Obes (Lond)27 May 2026
SGLT2 inhibitors are associated with reductions in epicardial adipose tissue volume and thickness: a meta-analysis
Meta-analysis
Diabetes Obes Metab27 May 2026
Randomised Controlled Feasibility Trial of Face‐To‐Face Diabetes Self‐Management Education Shows High Completion Rates Are Needed to Improve Patient‐Reported Outcomes
Randomized controlled trial
Diabetes Res Clin Pract26 May 2026
Remission of type 2 diabetes following a metabolic program including surgery: a comparative study of young-onset and older-onset type 2 diabetes
Cohort study
Cardiovasc Diabetol26 May 2026
Changes in cardiac myosin acetylation disrupt the super-relaxed state in genotype-negative hypertrophic cardiomyopathy with type 2 diabetes
Mechanistic study
Diabetes Res Clin Pract26 May 2026
Global burden of chronic kidney disease due to type 2 diabetes in adults from 1990 to 2021, with exploratory projections to 2036: a systematic analysis of the Global Burden of Disease Study 2021
Cohort study
Diabetes Res Clin Pract26 May 2026
Comprehensive drug safety assessment of sodium-glucose co-transporter 2 inhibitors, glucagon-like peptide 1 receptor agonists, and dipeptidyl peptidase 4 inhibitors: A Danish population-based active comparator new user cohort study
Cohort study
Ann Intern Med26 May 2026
Tirzepatide Versus Intensified Conventional Care After 2 Years of Treatment in Early Type 2 Diabetes : A Randomized Clinical Trial
Randomized controlled trial
Diabetes Res Clin Pract25 May 2026
Sarcopenia in Diabetes: A proposal on integrating muscle assessment and nutritional intervention in people living with diabetes
Guideline or statement
Diabetes Res Clin Pract25 May 2026
Screening gaps for prediabetes in US young adults under current American diabetes Association criteria
Cross-sectional study
Cardiovasc Diabetol25 May 2026
Effects of semaglutide on mortality, cardiovascular, and kidney outcomes across the cardio-kidney-metabolic continuum: a systematic review and meta-analysis
Meta-analysis
Diabetes Obes Metab25 May 2026
Impact of Time of Injection on the Efficacy and Safety of iGlarLixi Versus IDegAsp in Chinese People With Type 2 Diabetes: Exploratory Analysis of the Soli‐D Study
Secondary analysis
Diabetologia23 May 2026
A randomised clinical trial testing the safety of and metabolic responses to short-term duodenal infusion of recombinant RORDEP1 in healthy men
Randomized controlled trial
Lancet Diabetes Endocrinol22 May 2026
Effects of a 6-week subcutaneous infusion of native GIP alone or as add-on to semaglutide in people with type 2 diabetes: a single-centre, double-blind, parallel-group, randomised, placebo-controlled trial
Randomized controlled trial
Diabetologia22 May 2026
Age-related patterns of cardiometabolic risk factors for complications in type 2 diabetes
Cross-sectional study
BMJ Open Diabetes Res Care21 May 2026
Comparative effectiveness of sulfonylureas on kidney outcomes in adults with type 2 diabetes and moderate cardiovascular risk: a target trial emulation
Cohort study
Diabet Med21 May 2026
Language matters: Guidance for person‐centred diabetes communication in Ireland
Guideline or statement
Diabet Med21 May 2026
A systematic review and meta‐analysis of the relative benefit of dual versus single oral hypoglycaemic therapy following diagnosis with type 2 diabetes ( T2D )
Meta-analysis
Diabet Med21 May 2026
A retrospective sub‐study of perioperative glycaemia and insulin treatment for hospital inpatients at a quaternary centre from the specialist treatment of inpatients: Caring for diabetes in surgery trial ( STOIC ‐D Surgery)
Secondary analysis
Diabetes Obes Metab21 May 2026
Simplified Switching to Once‐Weekly Insulin Icodec Without an Initial One‐Time Additional Dose Versus Once‐Daily Insulin Glargine U100 in Basal Insulin‐Treated Type 2 Diabetes ( ONWARDS 10): A Randomised Controlled Trial
Randomized controlled trial
Diabetes Care20 May 2026
Comparing Approaches for Deriving Diabetes Care Cascades to Inform Policy: A Cross-sectional Analysis Using National Data From 88 Countries
Cross-sectional study
Diabetes Care20 May 2026
Precision Prescribing of SGLT2 Inhibitors in Individuals With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study
Diagnostic or prognostic study
Diabetes Care20 May 2026
Food Coloring Additives and Incidence of Type 2 Diabetes in the NutriNet-Santé Prospective Cohort
Cohort study
Diabetes Obes Metab20 May 2026
The Effects of Combined Antihypertensive and Antidiabetic Therapies on Cardiovascular Outcomes: A Systematic Review and Meta‐Analysis
Meta-analysis
Diabetes Res Clin Pract19 May 2026
Associations of grip strength and muscle mass with incident complications in patients with type 2 diabetes: a prospective cohort study
Cohort study
Diabetes Res Clin Pract18 May 2026
Glucagon-like peptide-1 receptor agonists and hair loss: A systematic review and meta-analysis
Meta-analysis
Diabetes Obes Metab18 May 2026
Association Between Glucagon‐Like Peptide‐1 Receptor Agonists and Suicidality: A Systematic Review
Meta-analysis
Diabetes Obes Metab18 May 2026
Association of GLP ‐1 Receptor Agonist Use With Safety Outcomes in Individuals With Opioid Use Disorder: A Target Trial Emulation
Cohort study
Cardiovasc Diabetol17 May 2026
Predicting cardiovascular death in overweight/obese people with prediabetes using machine learning—a proof-of-concept study
Diagnostic or prognostic study

All 4,758 Briefs in ExploreShowing Briefs 441–480 of 4,758, newest first